Bank of America told investors before Thursday’s close that one number would decide DocuSign’s fate this earnings cycle: the annual recurring revenue guidance. The company delivered. DocuSign raised its full-year ARR growth outlook to a range of 8.5% to 9.0%, up from the 8% ARR growth it reported in fiscal 2026. The stock responded accordingly. Shares rose about 7.3% in after-hours trading on Thursday, September 3, 2026.
The quarter itself was clean. Non-GAAP diluted EPS came in at $1.16, above consensus estimates around $1.08 to $1.09, and revenue reached $875.7 million versus expectations in the high $860 millions. Non-GAAP operating margin widened to 31.6%, up 180 basis points year-over-year. Net cash from operations reached $334.5 million, up from $246.1 million a year earlier, while free cash flow of $295.8 million represented a 34% margin, compared with $217.6 million and a 27% margin in the prior-year quarter. That is not the profile of a broken business.
The Business
DocuSign long ago stopped being just a digital signature company, though that franchise remains the foundation. The strategic emphasis has shifted toward its Intelligent Agreement Management platform, which automates agreement workflows, applies AI, and connects signing into broader business processes. The traction is measurable. IAM now represents 15.1% of total ARR, up from 12.6% in Q1, and management expects it to reach 18% to 19% of total ARR by fiscal year-end. CEO Allan Thygesen put it plainly on the earnings call: the company raised its outlook as AI tools gain traction with larger customers.
Customer growth accelerated to nearly 10% year-over-year, surpassing 1.9 million total customers, with the number of customers spending over $300,000 in annual contract value growing 14% year-over-year. That last figure matters most. It tells you the IAM upsell is landing at the enterprise level, not just at the margins.
Why Wall Street Is Paying Attention
DocuSign generated about $296 million in free cash flow in Q2 and repurchased roughly $307 million in stock, with diluted shares outstanding down to about 193 million from about 211 million a year earlier. The buyback is aggressive enough to be a meaningful earnings-per-share driver on its own. Combined with margin expansion, the company is compounding returns even in a period when top-line growth remains modest.
Shares had already gained about 10.2% over the past week and 13.7% over the past month heading into the results, suggesting some institutional positioning ahead of the quarter. The ARR guidance raise now validates that positioning.
What’s Driving the Opportunity
The bull case is straightforward: a dominant franchise with an 80%-plus non-GAAP gross margin, accelerating free cash flow, a credible AI platform gaining enterprise share, and a valuation that still looks compressed relative to software peers. DocuSign’s PEG ratio sits at 0.88, and return on invested capital is 23.23%. Those are not numbers that scream overvalued.
Adobe remains a major global competitor in e-signature, offering Adobe Acrobat Sign. But the IAM platform is expanding DocuSign’s addressable market well beyond basic signing, moving into contract lifecycle management, AI-powered agreement repositories, and end-to-end workflow automation. Full-year non-GAAP operating margin guidance of 31.0% to 31.5% puts the profitability story on firm footing.
What Could Go Wrong
The honest counterargument: 9% ARR growth is not a growth stock number. Investors who pay a software premium typically want 15% to 20% or higher. DocuSign is executing well inside a maturing e-signature market, and IAM adoption, while accelerating, still needs to prove it can move the top-line needle in a material way. Management also disclosed that Q2 revenue included about a 1.3 percentage point benefit from foreign exchange. Currency tailwinds can reverse. Competition from Adobe and from AI-native entrants building lightweight agreement tools is intensifying.
There is also the structural question about whether DocuSign can sustain margin expansion while investing meaningfully in IAM. Non-GAAP gross margins came in at 81.7%, down slightly compared to the prior year due to ongoing cloud migration investment. That is a manageable friction point today, but it signals the platform transition is not free.
The Bottom Line
DocuSign is not a high-growth story. It is a quality compounder at a reasonable price, delivering exactly what it said it would: widening margins, strong free cash flow, and a platform transition that is gaining measurable traction. The ARR guidance raise, the stronger free cash flow, and the enterprise customer acceleration all point in the same direction. The risk is that investors never fully rerate a company growing at single digits, however cheap it looks on cash flow. For investors who can live with that ceiling, DOCU today offers more evidence than it has in years that the business is moving in the right direction.
